Prime Minister Kishida has instructed Minister of Health, Labor and Welfare Goto to aim for practical application by the end of the year and accelerate efforts to secure the required amount of medicines that are expected to be the trump card for the new coronavirus. bottom.
In Japan, infusions for mildly ill patients used for antibody cocktail therapy, etc. have been approved for the treatment of the new coronavirus, but since management by a doctor is required, the development of a medicine that can be taken at home is being developed. It is expected.
Under these circumstances, Prime Minister Kishida, after a cabinet meeting, consulted with Minister of Health, Labor and Welfare Goto, aiming for the practical application of the new corona drug by the end of the year, and instructed to accelerate efforts to secure the required amount.
At a press conference, Minister Goto said, "We are providing assistance to support clinical trials, but we would like to proceed with approval as soon as possible and make preparations so that we can explain the specific securing situation and prospects to the people. It can be said that it is a trump card to ensure peace of mind, so I would like to do my best. "